Cognition Therapeutics Inc (CGTX) — Capital Reinvestment Ratio

Latest as of December 2021: 0.27x

Cognition Therapeutics Inc (CGTX) has a Capital Reinvestment Ratio of 0.27x as of December 2021, meaning it reinvests 0% of its operating cash flow ($101.00K) in capital expenditures ($27.00K). Check CGTX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.27x

Capex / Operating Cash Flow

Operating Cash Flow

$101.00K

USD

Capital Expenditures

$27.00K

USD

Data as of

Dec 2021

Most recent filing

Annual Capital Reinvestment Ratio for Cognition Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Cognition Therapeutics Inc from None to None. See Cognition Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow